DGAP-CMS: Siemens Healthineers AG: Release of a capital market information
2022. augusztus 01., hétfő, 15:00
Disclosure pursuant to Art. 5 para. 1 lit. b), para. 3 of the Regulation (EU) no. 596/2014 (MAR) in conjunction with Art. 2 para. 2, para. 3 of the Delegated Regulation (EU) No. 2016/1052 Share buyback – 5th Interim Reporting In the time period from and including 25 July 2022 until and including 29 July 2022, a number of 385,159 shares of Siemens Healthineers AG were bought back within the framework of the share buyback of Siemens Healthineers AG; on 27 June 2022, Siemens Healthineers AG disclosed pursuant to Art. 5 para. 1 lit. a) of the Regulation (EU) No. 596/2014 (MAR) in conjunction with Art. 2 para. 1 of the Delegated Regulation (EU) No. 2016/1052 the start of the share buyback on 29 June 2022. Shares were bought back as follows:
The transactions are published in a detailed form on the website of Siemens Healthineers AG (https://www.siemens-healthineers.com/investor-relations/share). The total volume of shares which were bought back within the framework of the share buyback in the time period from and including 29 June 2022 until and including 29 July 2022 amounts to 1,648,469 shares. The purchase of the shares of Siemens Healthineers AG is carried out by a credit institution that has been commissioned by Siemens Healthineers AG; the shares are repurchased exclusively on the electronic trading platform of the Frankfurt Stock Exchange (XETRA).
Munich, 01 August 2022 Siemens Healthineers AG The Managing Board ______________________________ 1Excluding incidental acquisition costs, rounded to four decimal places according to commercial practice.
|
Language: | English |
Company: | Siemens Healthineers AG |
Henkestr. 127 | |
91052 Erlangen | |
Germany | |
Internet: | https://www.siemens-healthineers.com |
End of News | DGAP News Service |
1410409 01.08.2022
Közzétételek - archívum
-
» PJSC Magnitogorsk Iron and Steel Works: MMK notifies on additional extension of consent solicitation process
[2022.06.30. 13:00]
-
» Evonik Industries and Laxxon Medical see future in 3D screen printed pharmaceuticals
[2022.03.08. 15:02]
-
» Evonik und Laxxon Medical sehen Zukunftsmarkt für 3D-Druck von Tabletten
[2022.03.08. 15:02]
-
» "Game Changing" Technology Enables QR Code Integration with 3D Screen Printing
[2022.02.16. 17:31]
-
» Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
[2022.01.07. 16:40]
-
» EQS-News: Focus Financial Partners Announces the Launch of Beryllus Capital in a Leading-Edge Joint Venture with the Hinduja Group
[2021.03.22. 12:45]
-
» DGAP-Adhoc: TRATON SE: TRATON und Navistar einig über Fortsetzung der Gespräche
[2020.10.16. 18:43]
-
» DGAP-Adhoc: TRATON SE: TRATON and Navistar agreement in principle
[2020.10.16. 18:43]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. Enters into Strategic Partnership with U.S.-Israeli Cannabis Innovation Lab
[2020.07.22. 15:00]
-
» EQS-News: International Cannabis Company Kaya Holdings, Inc. and Greek Joint Venture Partner to Launch "Cannamo(TM)" Brand of CBD Pet Products
[2020.07.08. 17:15]